pembrolizumab
merck
['keynote-604', 'sclc']
2 the keynote-604 study focused on untreated es-sclc patients. we used wes to evaluate tmb and determined an 18-gene t cell-inflamed gep (tcellinfgep) . also assessed? sclc transcriptional subtypes. #asco23 
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer